GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION
Clinical trials for GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for dry AMD: Long-Term drug shows promise in slowing vision loss
Disease control CompletedThis study looked at the long-term safety and effectiveness of a drug called pegcetacoplan in people with geographic atrophy, a late stage of dry age-related macular degeneration that causes vision loss. About 792 participants who had already been in earlier studies received the …
Matched conditions: GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION
Phase: PHASE3 • Sponsor: Apellis Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 06:10 UTC
-
New syringe design tested for eye disease treatment
Disease control CompletedThis study tested the safety of a drug called pegcetacoplan given through a prefilled syringe for people with geographic atrophy, a form of age-related macular degeneration that causes vision loss. 44 adults aged 60 and older received the injection in one eye. The goal was to see…
Matched conditions: GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION
Phase: PHASE3 • Sponsor: Apellis Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 05:49 UTC
-
Eye scans reveal clues to vision loss in dry AMD
Knowledge-focused CompletedThis study looked at 60 people with geographic atrophy, an advanced form of dry age-related macular degeneration that causes permanent vision loss. Researchers reviewed past eye exams and scans to see how vision loss relates to changes in the retina. No new treatments were tested…
Matched conditions: GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION
Sponsor: IRCCS Ospedale San Raffaele • Aim: Knowledge-focused
Last updated May 26, 2026 06:10 UTC